Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
39S ribosomal protein L1, mitochondrial (MRPL1) is a nuclear-encoded protein that is a component of the large (39S) subunit of the mitochondrial ribosome (mitoribosome). It belongs to the L1 family of ribosomal proteins and is essential for protein synthesis within the mitochondrion. MRPL1 is involved in the structure and function of the mitoribosome, particularly in regulating tRNA positioning and release from the E-site during mitochondrial translation. Mammalian mitochondrial ribosomes differ from prokaryotic ribosomes in protein composition and function, reflecting the unique requirements for protein synthesis in mitochondria[1][4][3]. MRPL1 is a highly conserved ribosomal protein critical for mitochondrial protein synthesis; while essential for cellular energy metabolism, it is not a direct drug target nor a disease-specific biomarker according to current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 39S ribosomal protein L1, mitochondrial (MRPL1).